CLB CORE LABORATORIES N V

NYSE corelab.com


$ 12.04 $ 0.19 (1.6 %)    

Tuesday, 21-Oct-2025 15:59:54 EDT
QQQ $ 610.99 $ 0.00 (0 %)
DIA $ 469.20 $ 0.00 (0 %)
SPY $ 671.63 $ 0.00 (0 %)
TLT $ 92.00 $ 0.00 (0 %)
GLD $ 377.96 $ 0.00 (0 %)
$ 12.04
$ 11.92
$ 12.03 x 1
$ 12.34 x 104
-- - --
$ 9.72 - $ 21.78
355,953
na
561.84M
$ 1.15
$ 23.69
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-27-2023 03-31-2023 10-Q
2 02-10-2023 12-31-2022 10-K
3 10-28-2022 09-30-2022 10-Q
4 07-28-2022 06-30-2022 10-Q
5 04-28-2022 03-31-2022 10-Q
6 02-10-2022 12-31-2021 10-K
7 10-28-2021 09-30-2021 10-Q
8 07-30-2021 06-30-2021 10-Q
9 04-23-2021 03-31-2021 10-Q
10 02-08-2021 12-31-2020 10-K
11 10-22-2020 09-30-2020 10-Q
12 07-24-2020 06-30-2020 10-Q
13 04-24-2020 03-31-2020 10-Q
14 02-10-2020 12-31-2019 10-K
15 10-25-2019 09-30-2019 10-Q
16 07-26-2019 06-30-2019 10-Q
17 04-26-2019 03-31-2019 10-Q
18 02-11-2019 12-31-2018 10-K
19 10-25-2018 09-30-2018 10-Q
20 07-27-2018 06-30-2018 10-Q
21 04-27-2018 03-31-2018 10-Q
22 02-12-2018 12-31-2017 10-K
23 10-25-2017 09-30-2017 10-Q
24 07-26-2017 06-30-2017 10-Q
25 04-21-2017 03-31-2017 10-Q
26 02-10-2017 12-31-2016 10-K
27 10-21-2016 09-30-2016 10-Q
28 07-22-2016 06-30-2016 10-Q
29 04-22-2016 03-31-2016 10-Q
30 02-12-2016 12-31-2015 10-K
31 10-23-2015 09-30-2015 10-Q
32 07-27-2015 06-30-2015 10-Q
33 04-29-2015 03-31-2015 10-Q
34 02-17-2015 12-31-2014 10-K
35 11-04-2014 09-30-2014 10-Q
36 07-25-2014 06-30-2014 10-Q
37 04-25-2014 03-31-2014 10-Q
38 02-13-2014 12-31-2013 10-K
39 10-18-2013 09-30-2013 10-Q
40 07-19-2013 06-30-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stifel-maintains-hold-on-core-laboratories-lowers-price-target-to-12

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $13 to $12.

 citigroup-maintains-neutral-on-core-laboratories-lowers-price-target-to-13

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $16 to...

 core-laboratories-sees-q2-gaap-eps-017-021-vs-024-est-sees-sales-128000m-134000m-vs-13601m-est

Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.17-$0.21 vs $0.24 analyst estimate. sees sales of $128.000 millio...

 core-laboratories-q1-adj-eps-014-misses-019-estimate-sales-12358m-miss-12980m-estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.1...

 stifel-maintains-hold-on-core-laboratories-lowers-price-target-to-15

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $19 to $15.

 citigroup-upgrades-core-laboratories-to-neutral-raises-price-target-to-16

Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and raises the price target from $...

 citigroup-maintains-sell-on-core-laboratories-raises-price-target-to-15

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and raises the price target from $14 to $15.

 core-laboratories-expects-q1-revenue-of-121m---127m-est-129237m-eps-of-012---016-est-023

Core expects to continue generating positive FCF in future quarters. 

 core-laboratories-q4-2024-adj-eps-022-inline-sales-12924m-miss-13244m-estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which met the analyst consensus estimate. This is a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION